Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Lu

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|April 9, 2026
Quantitative Systems Pharmacology Modeling Amid the Rise of Agentic AIJames Lu, Rajat Desikan
NPJ Systems Biology and Applications|November 18, 2023
Explainable deep learning for tumor dynamic modeling and overall survival prediction using Neural-ODEMark Laurie, James Lu
JCO Clinical Cancer Informatics|April 2, 2021
Computing the Hazard Ratios Associated With Explanatory Variables Using Machine Learning Models of Survival DataSameer Sundrani, James Lu
Iscience|September 4, 2023
REFINED-CNN framework for survival prediction with high-dimensional featuresOmid Bazgir, James Lu
BMC Bioinformatics|November 26, 2013
Mapping behavioral specifications to model parameters in synthetic biologyHeinz Koeppl, Marc Hafner, James Lu
Journal of Mathematical Biology|April 25, 2012
Inverse problems from biomedicine: inference of putative disease mechanisms and robust therapeutic strategiesJames Lu, Elias August, Heinz Koeppl
CPT: Pharmacometrics & Systems Pharmacology|April 1, 2021
Pharm-AutoML: An open-source, end-to-end automated machine learning package for clinical outcome predictionGengbo Liu, Dan Lu, James Lu
International Journal of Semantic Computing|December 27, 2014
Enabling Ontology Based Semantic Queries in Biomedical Database SystemsShuai Zheng, Fusheng Wang, James Lu
Algorithms for Molecular Biology : AMB|July 25, 2006
Inverse bifurcation analysis: application to simple gene systemsJames Lu, Heinz W Engl, Peter Schuster
Clinical Pharmacology and Therapeutics|October 13, 2023
Machine Learning-Based Quantification of Patient Factors Impacting Remission in Patients With Ulcerative Colitis: Insights from Etrolizumab Phase III Clinical TrialsRashed Harun, James Lu, Nastya Kassir, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
CPT: Pharmacometrics & Systems Pharmacology|April 9, 2026
Quantitative Systems Pharmacology Modeling Amid the Rise of Agentic AIJames Lu, Rajat Desikan
NPJ Systems Biology and Applications|November 18, 2023
Explainable deep learning for tumor dynamic modeling and overall survival prediction using Neural-ODEMark Laurie, James Lu
JCO Clinical Cancer Informatics|April 2, 2021
Computing the Hazard Ratios Associated With Explanatory Variables Using Machine Learning Models of Survival DataSameer Sundrani, James Lu
Iscience|September 4, 2023
REFINED-CNN framework for survival prediction with high-dimensional featuresOmid Bazgir, James Lu
BMC Bioinformatics|November 26, 2013
Mapping behavioral specifications to model parameters in synthetic biologyHeinz Koeppl, Marc Hafner, James Lu
Journal of Mathematical Biology|April 25, 2012
Inverse problems from biomedicine: inference of putative disease mechanisms and robust therapeutic strategiesJames Lu, Elias August, Heinz Koeppl
CPT: Pharmacometrics & Systems Pharmacology|April 1, 2021
Pharm-AutoML: An open-source, end-to-end automated machine learning package for clinical outcome predictionGengbo Liu, Dan Lu, James Lu
International Journal of Semantic Computing|December 27, 2014
Enabling Ontology Based Semantic Queries in Biomedical Database SystemsShuai Zheng, Fusheng Wang, James Lu
Algorithms for Molecular Biology : AMB|July 25, 2006
Inverse bifurcation analysis: application to simple gene systemsJames Lu, Heinz W Engl, Peter Schuster
Clinical Pharmacology and Therapeutics|October 13, 2023
Machine Learning-Based Quantification of Patient Factors Impacting Remission in Patients With Ulcerative Colitis: Insights from Etrolizumab Phase III Clinical TrialsRashed Harun, James Lu, Nastya Kassir, et al.
Pageof 7